PE/Cyanine7 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PECy7_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
  • M1slash70_PECy7_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
101215 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101216 100 µg 169€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang L, et al. 2021. J Nanobiotechnology. 19:56. PubMed
  2. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  3. Cheresh P, et al. 2021. Int J Mol Sci. 22:. PubMed
  4. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  5. Odom CV, et al. 2021. J Immunol. 207:1891. PubMed
  6. Hatzi K, et al. 2019. Nat Immunol. 20:86. PubMed
  7. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  8. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  9. Okunuki Y, et al. 2018. Proc Natl Acad Sci U S A. 115:E6264. PubMed
  10. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  11. Parsons M, et al. 2014. J Immunol. 192:1361. PubMed
  12. Tebartz C, et al. 2015. J Immunol. 194:1100. PubMed
  13. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  14. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  15. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  16. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  17. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  18. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  19. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  20. Jung MY, et al. 2022. Neurooncol Adv. 4:vdac017. PubMed
  21. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  22. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  23. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  24. Li Z, et al. 2021. Immunology. 163:105. PubMed
  25. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  26. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  27. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  28. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  29. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  30. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  31. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  32. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  33. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  34. Correa S, et al. 2020. ACS Nano. 2224:14. PubMed
  35. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  36. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  37. Wei H, et al. 2021. Malar J. 20:89. PubMed
  38. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  39. Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
  40. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  41. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  42. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  43. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  44. Chen T, et al. 2021. JCI Insight. 6:. PubMed
  45. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  46. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  47. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  48. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  49. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  50. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  51. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  52. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  53. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  54. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  55. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  56. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  57. Saggu G, et al. 2018. Nat Commun. 9:5058. PubMed
  58. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  59. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  60. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  61. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  62. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  63. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  64. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  65. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  66. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  67. Akhmetzyanova ER, et al. 2019. Front Cell Neurosci. 12:507. PubMed
  68. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  69. Gibson EM, et al. 2019. Cell. 176:43:00. PubMed
  70. Juttukonda LJ, et al. 2017. Cell Host Microbe. 22:531. PubMed
  71. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  72. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  73. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  74. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  75. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  76. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  77. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  78. Walker FC, et al. 2021. PLoS Pathog. 17:e1009402. PubMed
  79. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  80. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  81. Beauchamp EM, et al. 2021. Blood Cancer Discov. 6:. PubMed
  82. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  83. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  84. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  85. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  86. Klopfenstein N, et al. 2021. PLoS Pathog. 17:e1009387. PubMed
  87. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  88. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  89. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  90. Vazquez S, et al. 2015. Exp Hematol. 43: 578-585. PubMed
  91. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  92. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  93. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  94. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  95. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  96. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  97. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  98. Meeks K, et al. 2009. J Immunol. 183:8026. PubMed
  99. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  100. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  101. Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
  102. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  103. Goldman E, et al. 2021. Cells. 10:. PubMed
  104. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  105. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  106. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  107. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  108. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  109. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  110. Kirschbaum K, et al. 2016. Proc Natl Acad Sci U S A. 113: 13227 - 13232. PubMed
  111. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  112. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  113. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  114. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  115. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  116. Secondini C, et al. 2017. Oncoimmunology. 6:e1316437. PubMed
  117. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  118. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  119. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  120. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  121. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  122. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  123. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  124. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  125. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  126. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  127. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  128. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  129. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  130. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  131. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  132. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  133. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  134. Bambouskova M, et al. 2021. Cell Reports. 34(10):108756. PubMed
  135. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  136. Pérez-Girón J, et al. 2015. J Vis Exp. 100: 52803. PubMed
  137. Li H, et al. 2020. Nature. 584:274. PubMed
  138. Sibilio A, et al. 2022. iScience. 25:103790. PubMed
  139. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  140. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  141. Liu H, et al. 2022. Front Pharmacol. 13:949316. PubMed
  142. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  143. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  144. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  145. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  146. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  147. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  148. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  149. Boulay A, et al. 2015. J Neurosci. 35:4427. PubMed
  150. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  151. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  152. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  153. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  154. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  155. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  156. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  157. Gao C, et al. 2017. Mol Neurobiol.. 10.1007/s12035-016-0318-0. PubMed
  158. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  159. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  160. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  161. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  162. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  163. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  164. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  165. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  166. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  167. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  168. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  169. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  170. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  171. Scholz F, et al. 2015. J Immunol. 195: 2335-2342. PubMed
  172. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  173. Kim SJ, et al. 2020. Cell Mol Immunol. 17:728. PubMed
  174. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  175. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  176. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  177. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  178. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  179. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  180. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  181. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  182. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  183. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  184. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  185. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  186. Ivan DC, et al. 2021. Front Immunol. 12:666961. PubMed
  187. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
  188. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  189. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  190. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  191. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  192. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  193. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  194. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  195. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  196. Moro T, et al. 2016. PLoS One. 11: 0146592. PubMed
  197. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  198. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  199. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  200. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  201. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  202. Sun L, et al. 2022. Adv Sci (Weinh). 9:e2104051. PubMed
  203. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  204. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  205. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  206. Gourvest M, et al. 2021. Leukemia. . PubMed
  207. Beauchamp N, et al. 2010. J Virol. 84:10191. PubMed
  208. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  209. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  210. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  211. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  212. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  213. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  214. Baratin M, et al. 2017. Immunity. 47:349. PubMed
  215. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  216. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  217. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  218. Gicheva N, et al. 2016. Biochem Biophys Res Commun. 479:1-4. PubMed
  219. Molgora M, et al. 2020. Cell. 182:886. PubMed
  220. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  221. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  222. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  223. Rosen DA, et al. 2019. Sci Transl Med. 11:eaau5266. PubMed
  224. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  225. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  226. Süß P, et al. 2020. Cell Reports. 30(12):4082-4095. PubMed
  227. McPhee C, et al. 2013. J Immunol. 191:4581. PubMed
  228. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  229. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  230. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  231. Shin M, et al. 2020. Cell Chem Biol. 314:27. PubMed
  232. Kaiser S, et al. 2020. Glia. 2427:68. PubMed
  233. Aggio-Bruce R, et al. 2020. Mol Neurobiol. . PubMed
  234. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  235. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  236. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  237. Monteiro LB, et al. 2020. MethodsX. 7:100938. PubMed
  238. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  239. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  240. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  241. Chavez JS, et al. 2022. Cells. 11:. PubMed
  242. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  243. Alfaro M, et al. 2008. Proc Natl Acad Sci U S A. 105:18366. PubMed
  244. Walker JA, et al. 2020. Immunity. 51(1):104-118. PubMed
  245. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  246. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  247. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  248. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  249. Groppa E, et al. 2015. EMBO Mol Med. 2015; 7: 1366 - 1384. PubMed
  250. Gharib S, et al. 2014. J Leukoc Biol. 95:9. PubMed
  251. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  252. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  253. Franklin R, et al. 2022. Nat Commun. 13:2350. PubMed
  254. Gawish R, et al. 2022. Elife. 11:. PubMed
  255. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  256. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  257. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  258. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  259. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  260. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  261. Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed
  262. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  263. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  264. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  265. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  266. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  267. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  268. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  269. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  270. Lalor R, et al. 2019. Nutrients. 11. PubMed
  271. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  272. Young K, et al. 2021. Cell Stem Cell. . PubMed
  273. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  274. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  275. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
RRID
AB_312798 (BioLegend Cat. No. 101215)
AB_312799 (BioLegend Cat. No. 101216)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC, IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, IHC-F, ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC, IHC-F, 3D IHC, SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC, 3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC, ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, Block, Depletion, IHC-F, ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC, CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F, FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account